An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Incidence and prevalence of Systemic Sclerosis-associated Interstitial Lung Disease in a multicenter prospective cohort study. Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Patients in randomized clinical trials of bronchiectasis are only partially representative of clinical practice: A European cohort study Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015
Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021 Year: 2022
Prospective observational study in patients with obstructive lung disease: NOVELTY design Source: ERJ Open Res, 5 (1) 00036-2018; 10.1183/23120541.00036-2018 Year: 2019
Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018
Late Breaking Abstract - Identification of obstructive lung disease in Austrian pharmacies - a multi-site, cross-sectional case finding study Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
The EMBARC European Bronchiectasis Registry: protocol for an international observational study Source: ERJ Open Res 2016 Year: 2016
A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes Source: International Congress 2019 – Interventional pulmonology: a mixture of spices Year: 2019
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe. Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021
Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Late Breaking Abstract - COVID-19 in patients with pulmonary hypertension: a national prospective cohort study Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021